The treatment of severe acquired aplastic anemia

Blood

Volumn 85, Issue 12, 1995, Pages 3367-3377

  Young, Neal S ^a,b   Barrett, A John ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; STEM CELL FACTOR; THROMBOPOIETIN; THYMOCYTE ANTIBODY;

ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; CYTOTOXIC T LYMPHOCYTE; GRAFT VERSUS HOST REACTION; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0029059073     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v85.12.3367.bloodjournal85123367     Document Type: Review

References (123)

1. Thomas ED, Storb R, Fefer A, Slichter SJ, Bryant JI, Buckner CD, Neiman PE, Clift RA, Funk DD, Lerner KE: Aplastic anaemia treated by marrow transplantation. Lancet 1:284, 1972
2. Bortin MM, Gale RP, Rimm AA: Allogeneic bone marrow transplantation for 144 patients with severe aplastic anemia. JAMA 245:1132, 1981
3. Camitta BM, Thomas D, Nathan DG, Gale RP, Kopecky KJ, Rappeport JM, Santos G, Gordon-Smith EC, Storb R: A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood 53:504, 1979
4. Young NS, Alter BP: Aplastic Anemia, Acquired and Inherited. Philadelphia. PA, Saunders, 1994
5. Armitage JO: Bone marrow transplantation. N Engl J Med 330:827, 1994
6. Deeg HJ, Klingemann H-G, Phillips GL: A Guide to Bone Marrow Transplantation. Berlin, Germany, Springer-Verlag, 1992
7. Treleaven JG, Barrett AJ (eds): Bone Marrow Transplantation in Practise. London, UK, Churchill Livingston, 1992
8. Gordon-Smith EC (ed): Aplastic Anaemia, London, UK, Baillière Tindall, 1989
9. Schrezenmeier H, Gerok M, Heimpel H, Raghavachar A: Assessment of frequency of hematopoietic stem cells in aplastic anemia by limiting dilution type long term marrow culture. Exp Hematol 20:806, 1992 (abstr)
10. Maciejewski JP, Anderson S, Katevas P, Young NS: Phenotypic and functional analysis of the bone marrow progenitor cell compartment in aplastic anemia. Br J Haematol 87:227, 1994
11. Kaufman DW, Kelly JP, Levy M, Shapiro S: The Drug Etiology of Agranulocytosis and Aplastic Anemia. New York, NY. Oxford, 1991
12. Marsh JCW, Chang J, Testa NG, Hows JM, Dexter TM: In vitro assessment of marrow 'stem cell' and stromal cell function in aplastic anaemia. Br J Haematol 78:258, 1991
13. Holmberg LA, Seidel K, Leisenring W, Torok-Storb B: Aplastic anemia: Analysis of stromal cell function in long-term marrow cultures. Blood 84:3685, 1994
14. Maciejewski JP, Hibbs JR, Anderson S, Katevas P, Young NS: Bone marrow and peripheral blood lymphocyte phenotype in patients with bone marrow failure. Exp Hematol 22:1102, 1994
15. Selleri C, Anderson S, Young NS, Maciejewski JP: Interferon-γ and tumor necrosis factor-α suppress early and late stages of hematopoiesis in vitro and induce programmed cell death. Blood 84:215a, 1994 (abstr, suppl 1)
16. + human marrow cells is induced by interferon-gamma and tumor necrosis factor-alpha and potentiates hematopoietic suppression in vitro. Blood 85:3183, 1995
17. Nakao S, Yamaguchi M, Shiobara S: Interferon gamma gene expression in unstimulated bone marrow mononuclear cells predicts a response to cyclosporine therapy in aplastic anemia. Blood 79:2532, 1992
18. Nisticò A, Young NS: γ-Interferon gene expression in the bone marrow of patients with acquired aplastic anemia. Ann Intern Med 120:463, 1994
19. Nimer SD, Ireland P, Meshkinpour A, Frane M: An increased HLA DR2 frequency is seen in aplastic anemia patients. Blood 84:923, 1994
20. Nakao S, Takamatsu H, Shiobara S, Schrezenmeier H, Frickhofen N, Matsuda T, Kaneshige T, Mizoguchi H: Susceptibility to relapse of aplastic anemia after successful immunosuppressive therapy is closely associated with an HLA class II haplotype. Blood 84:215a, 1994 (abstr, suppl 1)
21. Storb R: Bone marrow transplantation for aplastic anemia. Cell Transplant 2:365, 1994
22. Bacigalupo A: Severe Aplastic Anaemia Working Party, in EBMT Working Parties Reports. Harrogate, UK, European Group for Bone Marrow Transplantation, 1994, p 49
23. Storb R, Weiden PL, Sullivan KM, Appelbaum FR, Beatty P, Buckner CD, Clift RA, Doney KC, Hansen J, Martin PJ, Sanders JE, Stewart P, Witherspoon RP, Thomas ED: Second marrow transplants in patients with aplastic anemia rejecting the first graft: Use of a conditioning regimen including cyclophosphamide and antithymocyte globulin. Blood 70:116, 1987
24. McCann SR, Bacigalupo A, Gluckman E, Hinterberger W, Hows J, Ljungman P, Marin P, Nissen C, van't Veer Kerthof E, Raghavachar A, Socie G, Frickhofen N, Locasciulli A, Schrezenmeier H: Graft rejection and second bone marrow transplants for aplastic anemia: a report from the Aplastic Anaemia Working Party of the European Bone Marrow Transplant Group. Bone Marrow Transplant 13:233, 1994
25. Deeg HJ, Self S, Storb R, Doney K, Appelbaum FR, Witherspoon RP, Sullivan KM, Sheehan K, Sanders J, Michelson E, Thomas ED: Decreased incidence of marrow graft rejection in patients with severe aplastic anemia: Changing impact of risk factors. Blood 68:1363, 1986
26. Storb R, Thomas ED, Buckner CD, Clift RA, Deeg HJ, Fefer A, Goodell BW, Sale GE, Sanders JE, Singer J, Stewart P, Weiden PL: Marrow transplantation in thirty "untransfused" patients with severe aplastic anemia. Ann Intern Med 92:30, 1980
27. Champlin RE, Horowitz MM, vanBekkum DW, Camitta BM, Elfenbein GE, Gale RP. Gluckman E, Good RA, Rimm AA, Rozman C, Speck B, Bortin MM: Graft failure following bone marrow transplantation for severe aplastic anemia: Risk factors and treatment results. Blood 73:606, 1989
28. Bordin JO, Heddle NM, Blajchman MA: Biologic effects of leuckocytes present in transfused cellular blood products. Blood 83:1703, 1994
29. Socié G, Henry-Amar M, Bacigalupo A, Hows J, Tichelli A, Ljungman P, McCann SR, Frickhofen N, Van't Veer-Korthof EV, Gluckman E: Malignant tumors occurring after treatment of aplastic anemia. N Engl J Med 329:1152, 1993
30. Deeg HJ, Socié G, Schoch G, Henry-Amar M, Witherspoon RP, Gluckman E, Storb R: New malignancies in patients with aplatic anemia treated by marrow transplantation: Analysis of the Seattle and Paris results. Blood 84:249a, 1994 (abstr, suppl 1)
31. Smith BR, Guinan EC, Parkman R, Ferrera JM, Levey RH, Nathan DG, Rappeport JM: Efficacy of a cyclophosphamide-procarbazine-antithymocyte serum regimen for prevention of graft rejection following bone marrow transplantation for transfused patients with aplastic anemia. Transplantation 39:671, 1984
32. Hows J, Palmer S, Gordon-Smith EC: Cyclosporine and graft failure following bone marrow transplantation for severe aplastic anemia. Br J Haematol 60:611, 1985
33. May WS, Sensenbrenner LL, Burns WH, Ambinder R, Carroll MP, Griffin CA, Jones RJ, Miller CB, Mellitis ED, Vogelsang GB, Wagner JE, Wingard JR, Yeager AM, Santos GW: BMT for severe aplastic anemia using cyclosporine. Bone Marrow Transplant 11:459, 1993
34. Storb R, Thomas ED, Weiden PL, Buckner CD, Clift RA, Fefer A, Fernando LP, Giblett ER, Goodell BW, Johnson FL, Lerner KG, Neiman PE, Sanders JE: Aplastic anemia treated by allogeneic bone marrow transplantation: A report on 49 new cases from Seattle. Blood 48:817, 1976
35. Storb R, Etzioni R, Anasetti C, Appelbaum FR, Buckner CD, Bensinger W, Bryant E, Clift R, Deeg HJ, Doney K, Flowers M, Hansen J, Martin P, Pepe M, Sale G, Sanders J, Singer J, Sullivan KM, Thomas ED, Witherspoon RP: Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. Blood 84:941, 1994
36. Ferrara JLM, Deeg HJ: Graft-versus-host disease. N Engl J Med 324:667, 1991
37. Deeg HJ, Cottier-Fox M: Clinical spectrum and pathophysiology of acute graft-versus-host disease, in Burakoff SJ, Deeg HJ, Ferrara J, Atkinson H (eds): Graft-vs.-Host Disease. Immunology, Pathophysiology, and Treatment. New York, NY, Marcel-Dekker, 1990, p 311
38. Atkinson K, Horowitz MM, Gale RP, van Bekkum DW, Gluckman E, Good RA, Jacobsen N, Kolb H, Rimm AA, Ringden O, Ciril R, Sobocinski KA, Zwaan FE, Bortin MM: Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood 75:2459, 1990
39. Ochs LA, Miller WJ, Filipovich AH, Haake RJ, McGlave PB, Blazar BR, Ramsay NKC, Kersey JH, Weisdorf DJ: Predictive factors for chronic graft-versus-host disease after histocompatible sibling donor bone marrow transplantation. Bone Marrow Transplant 13:455, 1994
40. Storb R, Prentice RL, Sullivan KM, Shulman HM, Deeg HJ, Doney KC, Buckner CD, Clift RA, Witherspoon RP, Appelbaum FA, Sanders JE, Stewart PS, Thomas ED: Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings. Ann Intern Med 98:461, 1983
41. Sanders JE, Storb R, Anasetti C, Deeg HJ, Doney K, Sullivan KM, Witherspoon RP, Hansen J: Marrow transplant experience for children with severe aplatic anemia. Am J Pediatr Hematol Oncol 16:43, 1994
42. Sobocinski KA, Horowitz MM, Rowlings PA, Zhang M-J, Nugent ML, Passweg JR, Armitage JO, Gale RP, Bortin MM: Bone marrow transplantation - 1994: A report from the International Bone Marrow Transplant Registry and the North American Autologous Bone Marrow Transplant Registry. J Hematother 3:95, 1994
43. Klingemann H-G, Storb R, Fefer A, Deeg HJ, Appelbaum FR, Buckner CD, Cheever MA, Greenberg PD, Stewart PS, Sullivan KM, Witherspoon RP, Thomas ED: Bone marrow transplantation in patients aged 45 years and older. Blood 67:770, 1986
44. Storb R, Deeg HJ, Pepe M, Doney K, Appelbaum F, Beatty P, Bensinger W, Buckner CD, Clift R, Hansen J, Hill R, Longton G, Anasetti C, Martin P, Loughran TP, Sanders J, Singer J, Stewart P, Sullivan KM, Witherspoon R, Thomas ED: Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: Long-term follow-up of a controlled trial. Br J Haematol 72:567, 1989
45. Hows JM, Marsh JC, Yin JL, Durrant S, Swirsky D, Worsley A, Fairhead SM, Chipping PM, Palmer S, Gordon-Smith EC: Bone marrow transplantation for severe aplastic anaemia using cyclosporin: Long-term follow-up. Bone Marrow Transplant 4:11, 1989
46. Gluckman E, Horowitz MM, Champlin RE, Hows JM, Bacigalupo A, Biggs JC, Camitta BM, Gale RP, Gordon-Smith EC, Marmont AM, Masaoka T, Ramsay NKC, Rimm AA, Rozman C, Sobocinski KA, Speck B, Bortin MM: Bone marrow transplantation for severe aplastic anemia: Influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome. Blood 79:269, 1992
47. Platanias L, Gascon P, Bielory L, Griffith P, Nienhuis AW, Young N: Lymphocyte subsets and lymphokines following antithymocyte globulin therapy in patients with aplastic anaemia. Br J Haematol 66:433, 1987
48. López-Karpovitch X, Zarzosa ME, Cárdenas MR, Piedras J: Changes in peripheral blood mononuclear cell subpopulations during antithymocyte globulin therapy for severe aplastic anemia. Acta Haematol 81:176, 1989
49. Gascon P, Zoumbos N, Djeu J, Scala G, Young N: Lymphokine abnormalities in aplastic anemia. Implications for the mechanism of action of ATG. Blood 65:407, 1985
50. Kawano Y, Nissen C, Gratwohl A, Speck B: Immunostimulatory effects of different antilymphocyte globulin preparations: A possible clue to their clinical effect. Br J Haematol 68:115, 1988
51. Nimer SD, Golde DW, Kwan K, Lee K, Clark S, Champlin R: In vitro production of granulocyte-macrophage colony stimulating factor in aplastic anemia: Possible mechanisms of action of antithymocyte globulin. Blood 78:163, 1991
52. de Planque MM, Bacigalupo A, Würsch A, Hows JM, Devergie A, Frickhofen N, Brand A, Nissen C: Long-term follow-up of severe aplastic anaemia patients treated with antithymocyte globulin. Br J Haematol 73:121, 1989
53. Young N, Speck B: Antithymocyte and antilymphocyte globulins: Clinical trials and mechanism of action, in Young NS, Levine AS, Humphries RK (eds): Aplastic Anemia. Stem Cell Biology and Advances in Treatment. New York, NY, Liss, 1984, p 221
54. Champlin R, Ho W, Gale RP: Antithymocyte globulin treatment in patients with aplastic anemia. N Engl J Med 308:113, 1983
55. Young N, Griffith P, Brittain E, Elfenbein G, Gardner F, Huang A, Harmon D, Hewlett J, Fay J, Mangan K, Morrison F, Sensenbrenner L, Shadduck R, Wang W, Zaroulis C, Zuckerman K: A multicenter trial of anti-thymocyte globulin in aplastic anemia and related diseases. Blood 72:1861, 1988
56. Raefsky E, Gascon P, Gratwohl A, Speck B, Young NS: Biological and biochemical characterization of anti-thymocyte globulins (ATG) and anti-lymphocyte globulins (ALG). Blood 68:712, 1986
57. Smith AG, O'Reilly RJ, Hansen JA, Martin PJ: Specific antibody-blocking activities in antilymphocyte globulin as correlates of efficacy for the treatment of aplastic anemia. Blood 66:721, 1985
58. Bonnefoy-Bérard N, Vincent C, Revillard J-P: Antibodies against functional leukocyte surface molecules in polyclonal antilymphocyte and antithymocyte globulins. Transplantation 51:669, 1991
59. Bielory L, Gascon P, Lawley T, Nienhuis AW, Young NS, Frank M: Human serum sickness: A prospective clinical analysis of 35 patients treated with equine anti-thymocyte globulin for bone marrow failure. Medicine 67:40, 1988
60. Bayever E, Champlin R, Ho W, Lenarsky C, Storch S, Ladisch S, Gale RP, Feig SA: Comparison between bone marrow transplantation and antithymocyte globulin in treatment of young patients with severe aplastic anemia. J Pediatr 105:920, 1984
61. Locasciulli A, van't Veer L, Bacigalupo A, Hows J, van Lint MT, Gluckman E, Nissen C, McCann S, Vossen J, Schrezenmeier A, Hinterberger W, Marin A: Treatment with marrow transplantation or immunosuppression of childhood acquired severe aplastic anemia: A report from the EBMT SAA working party. Bone Marrow Transplant 6:211, 1990
62. Halperin DS, Grisaru D, Freedman MH, Saunders EF: Severe acquired aplastic anemia in children: 11-Year experience with bone marrow transplantation and immunosuppressive therapy. Am J Pediatr Hematol Oncol 11:304, 1989
63. Bacigalupo A, Hows J, Gluckman E, Nissen C, Marsh J, van Lint MT, Congiu M, DePlanque MM, Ernst P, McCann S, Ragavashar A, Frickhofen N, Wursch A, Marmont AM, Gordon-Smith EC: Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): A report of the EBMT SAA working party. Br J Haematol 70:177, 1988
64. Shahidi NT, Wang WC, Shurin SB, Finlay JL, Sondel PM, Dinndorf PA: Treatment of acquired aplastic anemia with cyclosporine and androgens, in Shahidi NT (ed): Aplastic Anemia and Other Bone Marrow Failure Syndromes. London, UK, Springer-Verlag, 1990, p 155
65. Leonard EM, Raefsky E, Griffith P, Kimball J, Nienhuis AW, Young NS: Cyclosporine therapy of aplastic anaemia, congenital and acquired red cell aplasia. Br J Haematol 72:278, 1989
66. Hinterberger-Fisher M, Höcker P, Lechner K, Seewann H, Hinterberger W: Oral cyclosporin-A is effective treatment for untreated and also for previously immunosuppressed patients with severe bone marrow failure. Eur J Hematol 43:136, 1989
67. Gluckman E, Esperou-Bourdeau H, Baruchel A, Boogaerts M, Briere J, Donadio D, Leverger G, Leporrier M, Reiffers J, Janvier M, Michallet M, Stryckmans P: Multicenter randomized study comparing cyclosporine-A alone and antithymocyte globulin with prednisone for treatment of severe aplastic anemia. Blood 79:2540, 1992
68. Leeksma OC, Thomas LLM, Van der Leslie J, Van Oers MHJ, von dem Borne AEGKr, Goudsmit R: Effectiveness of lowdose cyclosporine in acquired aplastic anaemia with severe neutropenia. Neth J Med 41:143, 1992
69. Schrezenmeier H, Schlander M, Raghavachar A: Cyclosporin A in aplastic anemia - Report of a workshop. Ann Hematol 65:33, 1992
70. Frickhofen N, Kaltwasser JP, Schrezenmeier H, Raghavachar A, Vogt HG, Herrmann F, Freund M, Meusers P, Salama A, Heimpel H: Treatment of aplastic anemia with antithymocyte globulin and methylprednisolone with or without cyclosporine. N Engl J Med 324:1297, 1991
71. Park CW, Han CH, Kim CC, Kim DJ: Immunomodulation therapy for severe aplastic anemia - ALG versus ALG plus cyclosporin A. Korean J Intern Med 4:28, 1989
72. Rosenfeld S, Kimball J, Vining D, Young NS: Intensive immunosuppression with antithymocyte globulin and cyclosporin as treatment for severe aplastic anemia. Blood 85:3058, 1995
73. Matloub YH, Bostrom B, Golembe B, Priest J, Ramsay NKC: Antithymocyte globulin, cyclosporine, and prednisone for the treatment of severe aplastic anemia in children. Am J Pediatr Hematol Oncol 16:104, 1994
74. Bacigalupo A, Broccia G, Corda G, Arcese W, Carotenuto M, Gallamini A, Locatelli F, Mori PG, Sarocco P, Todeschini A, Coser P, Iacopino P, van Lint MT, Gluckman E: Antilymphocyte globulin, cyclosporin and granulocyte colony stimulating factor in patients with acquired severe aplastic anemia (SAA): A pilot study of the EBMT SAA Working Party. Blood 85:1348, 1995
75. Bacigalupo A, van Lint MT, Cerri R, Giordano D, Santini G, Carella M, Damasio E, Rossi E, Risso M, Vimercati R, Podesta' M, Durando A, Reali G, Avanzi G, Barbanti M, Marmont AM: Treatment of severe aplastic anemia with bolus 6-methylprednisolone and antilymphocytic globulin. Blut 41:168, 1980
76. Speck B, Gratwhol A, Nissen C, Osterwalder B, Würsch A, Tichelli A, Lori A, Reusser P, Jeannet M, Signer E: Treatment of severe aplastic anemia. Exp Hematol 14:126, 1986
77. Doney K, Pepe M, Storb R, Bryant E, Anasetti C, Appelbaum FR, Buckner CD, Sanders J, Singer J, Sullivan K, Weiden P, Hansen JA: Immunosuppressive therapy of aplastic anemia: Results of a prospective, randomized trial of antithymocyte globulin (ATG), methylprednisolone, and oxymetholone to ATG, very high-dose methylprednisolone, and oxymetholone. Blood 79:2566, 1992
78. Marsh JCW, Zomas A, Hows JM, Chappie M, Gordon-Smith EC: Avascular necrosis after treatment of aplastic anaemia with antilymphocyte globulin and high-dose methylprednisolone. Br J Haematol 84:731, 1993
79. Schrezenmeier H, Marin P, Raghavachar A, McCann S, Hows J, Gluckman E, Nissen C, Van't Veer-Korthof ET, Ljungman P, Hinterberger W, van Lint MT, Frickhofen N, Bacigalupo A: Relapse of aplastic anaemia after immunosuppressive treatment: A report from the European Bone Marrow Transplantation Group SAA Working Party. Br J Haematol 85:371, 1993
80. Young NS: The problem of clonality in aplastic anemia. Dr. Dameshek's riddle, restated. Blood 79:1385, 1992
81. Tichelli A, Gratwohl A, Wursch A, Nissen C, Speck B: Late haematological complications in severe aplastic anaemia. Br J Haematol 69:413, 1988
82. Schubert J, Alvarado M, Uciechowski P, Zielinska-Skowronek M, Freund M, Vogt H, Schmidt RE: Diagnosis of paroxysmal nocturnal haemoglobinuria using immunophenotyping of peripheral blood cells. Br J Haematol 79:487, 1991
83. Shichishima T, Terasawa T, Saitoh Y, Hashimoto C, Ohto H, Maruyama Y: Diagnosis of paroxysmal nocturnal haemoglobinuria by phenotypic analysis of erythrocytes using two-colour flow cytometry with monoclonal antibodies to DAF and CD59/MACIF. Br J Haematol 85:378, 1993
84. Schrenzenmeier H, Hertenstein B, Wagner B, Raghavachar A, Heimpel H: A pathogenetic link between aplastic anemia and paroxysmal nocturnal hemoglobinuria is suggested by a high frequency of aplastic anemia with a deficiency of phosphatidylinositol glycan proteins. Exp Hematol 23:81, 1995
85. Narayanan MN, Geary CG, Freemont AJ, Kendra JR: Long-term follow-up of aplastic anaemia. Br J Haematol 86:837, 1994
86. Champlin RE, Nimer SD, Ireland P, Oette DH, Golde DW: Treatment of refractory aplastic anemia with recombinant human granulocyte-macrophage-colony-stimulating factor. Blood 73:694, 1989
87. Guinan EC, Sieff CA, Oette DH, Nathan DG: A phase I/ II trial of recombinant granulocyte-macrophage colony-stimulating factor for children with aplastic anemia. Blood 76:1077, 1990
88. Kojima S, Fukuda M, Miyajima Y, Matsuyama T, Horibe K: Treatment of aplastic anemia in children with recombinant human granulocyte colony-stimulating factor. Blood 77:937, 1991
89. Sonoda Y, Ohno Y, Fujii H, Takahashi T, Nakayama S, Haruyama H, Nasu K, Shimazaki C, Hara H, Kanamaru A, Kakishita E, Horiuchi A, Abe T, Masaoka T, Uchino H, Nagai K: Multilineage response in aplastic anemia patients following long-term administration of filgrastim (recombinant human granulocyte colony stimulating factor). Stem Cells 11:543, 1993
90. Ganser A, Lindemann A, Seipelt G, Ottmann OG, Eder M, Falk S, Herrmann F, Kaltwasser JP, Meusers P, Klausmann M, Frisch J, Schulz G, Mertelsman R, Hoelzer D: Effects of recombinant human interleukin-3 in aplastic anemia. Blood 76:1287, 1990
91. Nimer SD, Paquette RL, Ireland P, Resta D, Young D, Golde DW: A phase I/II study of interleukin-3 in patients with aplastic anemia and myelodysplasia. Exp Hematol 22:875, 1994
92. Marsh JCW, Socie G, Schrezenmeier H, Tichelli A, Gluckman E, Ljungman P, McCann SR, Raghavachar A, Marin P, Hows JM, Bacigalupo A: Haemopoietic growth factors in aplastic anaemia: A cautionary note. Lancet 344:172, 1994
93. Nemunaitis J, Anasetti C, Storb R, Bianco JA, Buckner CD, Onetto N, Martin P, Sanders J, Sullivan K, Mori M, Shannon-Dorcy K, Bowden R, Appelbaum FR, Hansen J, Singer JW: Phase II trial of recombinant human granulocyte-macrophage colony-stimulating factor in patients undergoing allogeneic bone marrow transplantation from unrelated donors. Blood 79:2572, 1992
94. Najean Y, Haguenauer O: Long-term (5 to 20 years) evolution of nongrafted aplastic anemia. Blood 76:2222, 1990
95. Gardner FH, Juneja HS: Androstane therapy to treat aplastic anaemia in adults: An uncontrolled pilot study. Br J Haematol 65:295, 1987
96. Champlin RE, Ho WG, Feig SA, Winston DJ, Lenarsky C, Gale RP: Do androgens enhance the response to antithymocyte globulin in patients with aplastic anemia? A prospective randomized trial. Blood 66:184, 1985
97. Bacigalupo A, Chaple M, Hows J, van Lint MT, McCann S, Milligan D, Chessels J, Goldstone AH, Ottolander J, Van't Veer ETh, Den Ostendorf GJ, Comotti V, Coser P, Broccia G, Bosi A, Locasciulli A, Catalano L, Battista R, Arcese W, Carotenuto M, Marmont AM, Gordon Smith EC: Treatment of aplastic anemia (AA) with antilymphocyte globulin (ALG) and methylprednisolone (MPred) with or without androgens: A randomized trial from the EBMT SAA working party. Br J Haematol 83:145, 1993
98. Beatty PG: The use of unrelated donors bone marrow transplantation. Marrow Transplant Rev 1:1, 1991
99. Santamaria P, Reinsmoen NL, Lindstrom AL, Boyce-Jacino MT, Barbosa JJ, Paras AJ, McGlave PB, Rich SS: Frequent HLA class I and DP sequence mismatches in serologically (HLA-A, HLA-B, HLA-DR) and molecularly (HLA-DRB1, HLA-DQA1, HLA-DQB1) HLA-identical unrelated bone marrow transplant pairs. Blood 83:280, 1994
100. Gordon-Smith EC, Hows J, Bacigalupo A, Gluckman E, van Lint MT, Congru A, James DCO, Barrett AJ, de Planque MM, Siimes MA, Toivanen A, Ringden O, Marmont AM: Bone marrow transplantation for severe aplastic anaemia (SAA) from donors other than HLA identical siblings: A report of the EBMT working party. Semin Hematol 21:100, 1994
101. Kernan NA, Bartsch G, Ash RC, Beatty PG, Champlin R, Filipovich A, Gajewski J, Hansen JA, Henslee-Downey J, McCullough J, McGlave P, Perkins HA, Phillips GL, Sanders J, Stroncek D, Thomas ED, Blume KG: Analysis of 462 transplantations from unrelated donors facilitated by the national marrow donor program. N Engl J Med 328:593, 1993
102. Bradley BA, Hows JM, Gore SM, Bidwell JL, Clay T, Downie TR, Gluckman E, Howard MR, Laundy GJ: Current status of unrelated-donor bone marrow transplatation. Clin Transplant 91, 1992
103. Hows JM, Downie TR, Bradley BA, Gore SM: Unrelated donor BMT for acquired SAA: European experience 1989-93. Bone Marrow Transplant 143, 1994 (abstr, suppl)
104. Camitta B, Casper J, Pietryga D, Garbrecht F, Ash R, Keever C, Murray K, Baxter-Lowe L, Flomenberg N: Unrelated donor marrow transplantation (BMT) for children with severe aplastic anemia. Blood 82:344a, 1993 (abstr, suppl 1)
105. Speck B, Tichelli A, Gratwohl A, Nissen C: Treatment of severe aplastic anemia: A 12-year follow-up of patients after bone marrow transplantation or after therapy with antilymphocyte globulin, in Shahidi NT (ed): Aplastic Anemia and Other Bone Marrow Failure Syndromes. London, UK, Springer-Verlag, 1990, p 96
106. Tichelli A, Gratwohl A, Nissen C, Singer E, Stebler-Gysi C, Speck B: Morphology in patients with severe aplastic anemia treated with antilymphocyte globulin. Blood 80:337, 1992
107. Paquette RL, Tebyani N, Franc M, Ireland P, Ho WG, Champlin RE, Nimer SD: Long-term outcome of aplastic anemia in adults treated with antithymocyte globulin: Comparison with bone marrow transplantation. Blood 85:283, 1995
108. Crump M, Larratt LM, Maki E, Curtis JE, Minden MD, Meharchand JM, Lipton JH: Treatment of adults with severe aplastic anemia: Primary therapy with antithymocyte globulin (ATG) and rescue of ATG failures with bone marrow transplantation. Am J Med 92:596, 1992
109. Jansen J, Gratama JW, Zwaan FE, Simonis RFA: Therapy with monoclonal antibody OKT3 in severe aplastic anemia. Exp Hematol 12:46, 1984 (suppl 15)
110. Schwinger W, Urban C, Lackner H, Mache C: Treatment of aplastic anemia with a monoclonal antibody directed against the interleukin-2 receptor. Ann Hematol 66:181, 1993
111. Gluckman E, Socié G, Devergie A, Bourdeau-Esperou H, Traineau R, Cosset JM: Bone marrow transplantation in 107 patients with severe aplastic anemia using cyclophosphamide and thoraco-abdominal irradiation for conditioning: Long-term follow-up. Blood 78:2451, 1991
112. Champlin RE, Ho WG, Nimer SD, Gajewski JG, Selch M, Burnison M, Holley G, Yam P, Petz L, Winston DJ, Feig SA: Bone marrow transplantation for severe aplastic anemia. Transplantation 49:720, 1990
113. Bortin MM, Horowitz MM, Rowlings PA, Rimm AA, Sobocinski KA, Zhang MJ, Gale RP: 1993 Progress report from the International Bone Marrow Transplant Registry. Bone Marrow Transplant 12:97, 1993 (abstr)
114. Pepe MS, Longston G, Pettinger M, Mori M, Fisher LD, Storb R: Summarizing data on survival, relapse, and chronic graft-versus-host disease after bone marrow transplantation: Motivation for and description of new methods. Br J Haematol 83:602, 1993
115. Storb R, Thomas ED, Buckner CD, Appelbaum FR, Clift RA, Deeg HJ, Doney K, Hansen JA, Prentice RL, Sanders JE, Stewart P, Sullivan KM, Witherspoon RP: Marrow transplantation for aplastic anemia. Semin Hematol 21:27, 1984
116. McGlave PB, Haake R, Miller W, Kim T, Kersey J, Ramsay NKC: Therapy of severe aplastic anemia in young adults and children with allogeneic bone marrow transplantation. Blood 70:1325, 1987
117. Dupont B, O'Reilly RJ, Pollack MS, Good RA: Use of HLA genotypically different donors in bone marrow transplantation. Transplant Proc 11:219, 1979
118. Gingrich RD, Ginder GD, Goeken NE, Howe CWS, Wen BC, Hussey DH, Fyfe MA: Allogeneic marrow grafting with partially mismatched, unrelated marrow donors. Blood 71:1375, 1988
119. Hows, JM, Yin JL, Marsh J, Swirsky D, Jones L, Apperley JF, James DCO, Smithers S, Goldman JM, Gordon-Smith EC: Histocompatible unrelated volunteer donors compared with HLA nonidentical family donors in marrow transplantation for aplastic anemia and leukemia. Blood 68:1322, 1986
120. Hows J, McKinnon S, Brookes P, Kaminski E, Bidwell J, Bradley B, Batchelor J, Goldman J: Matched unrelated donor transplantation. Transplant Proc 21:2923, 1989
121. Bacigalupo A, Hows J, Gordon-Smith EC, Gluckman E, van Lint MT, Congiu M, James DCO, Barren AJ, Gmur J, de Planque MM, Siimes MA, Toivanen A, Ringden O, Marmont AM: Bone marrow transplantation for severe aplastic anemia from donors other than HLA identical siblings: A report of the BMT working party. Bone Marrow Transplant 3:531, 1988
122. Camitta B, Ash R, Menitove J, Lawton C, Hunter J, Casper J: Bone marrow transplantation for children with severe aplastic anemia: Use of donors other than HLA-identical siblings. Blood 74:1852, 1989
123. Hows JM, Szydlo R, Anasetti C, Camitta B, Gajewski J, Gluckman E: Unrelated donor transplants for severe aplastic anemia. Bone Marrow Transplant 10:102, 1992 (suppl 1)